NCT01741649

Brief Summary

Many solutions are used for cleaning the skin of a patient previous to a surgery. Although the efficacy of clorhexidine has been proved in other surgical procedures, there is only a retrospective study in cesarean section (they report no benefit of one solution over the other). The investigators would like to evaluate the difference in surgical site infection in patients after cesarean section comparing preparation of the skin with clorhexidine versus povidone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 5, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

May 17, 2013

Status Verified

May 1, 2013

Enrollment Period

5 months

First QC Date

December 1, 2012

Last Update Submit

May 16, 2013

Conditions

Keywords

Surgical wound infectionClorhexidinePovidone

Outcome Measures

Primary Outcomes (1)

  • Surgical Site infection (SSI)

    The patients will be evaluated for evidence of surgical site infection before leaving the hospital, three (3) days after surgery. The presence of fever, suppurative secretion through the wound or cutaneous changes compatible witn infection will be considered a surgical site infection (SSI). This outcome will be evaluated with a qualitative variable (presence of SSI). The patients will be classified in accordance as "With SSI" or "Without SSI".

    3 days

Secondary Outcomes (1)

  • Hospitalization

    15 days

Study Arms (2)

Clorhexidine

EXPERIMENTAL

Skin prior to the surgical incision will be cleaned for five minutes with Clorhexidine.

Procedure: Clorhexidine

Povidone

EXPERIMENTAL

Skin prior to surgical incision will be cleaned for five minutes with a povidine solution.

Procedure: Povidone

Interventions

ClorhexidinePROCEDURE

Cleaning of the surgical site previous to the incision with a clorhexidine solution for five minutes.

Clorhexidine
PovidonePROCEDURE

Cleaning of the surgical site previous to the incision with a povidone solution for five minutes.

Povidone

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Gestational age \> 32 weeks
  • Emergency cesarean section

You may not qualify if:

  • Allergy to clorhexidine
  • Allergy to povidone
  • Evidence of infection in the surgical site
  • Loss to follow up at 15 days
  • Surgeries that due to the emergency of the case do not allow the five minutes of skin cleaning.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Thomas Maternity Hospital

Panama City, Provincia de Panamá, Panama

Location

MeSH Terms

Conditions

Surgical Wound Infection

Interventions

Povidone

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Coordinator of Research

Study Record Dates

First Submitted

December 1, 2012

First Posted

December 5, 2012

Study Start

October 1, 2012

Primary Completion

March 1, 2013

Study Completion

April 1, 2013

Last Updated

May 17, 2013

Record last verified: 2013-05

Locations